Home
Clinical Resources Search
PQI: Cabozantinib (Cabometyx®)

Cabozantinib (Cabometyx®)

Download PQI pdf 0.25MB

Last Updated: August 30, 2024

By: Collin Dempsey PharmD, BCPS

About this PQI

The purpose of this PQI is to provide a concise and comprehensive resource for proper medication management of patients utilizing Cabozantinib. Utilizing this resource should assist to decrease medication toxicities, improve medication adherence, and improve overall patient outcomes.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Hepatocellular Carcinoma (HCC) Renal Cell Carcinoma (RCC) Thyroid Cancer Cabometyx Cabozantinib

PQI

Frequently Searched

Supported by

Cabozantinib (Cabometyx®)

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Zolbetuximab (Vyloy®) for Gastroesophageal Cancers

PQI: Advances in MRD Monitoring for Diffuse Large B-Cell Lymphoma (DLBCL)

PQI: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI: Ibrutinib Dosing Optimization

PQI in Action: Larotrectinib (Vitrakvi®) Overview

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management

PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations

PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease

S8 Ep 13: Supporting Patients Through Financial Assistance

S8 Bonus Episode: ¡No Más Melanomas! – Updates in the Treatment of Cutaneous Melanoma

S8 Ep 12: Lorlatinib in Practice: 5 Years of Data, Real-World Counseling, and AE Management

S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024

Readiness Tracker

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Treatment Support Kit: Tivozanib

Treatment Support Kit: Regorafenib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Sorafenib (Nexavar®) for the Treatment of Hepatocellular Carcinoma and Transition to Second-line Regorafenib (Stivarga®)

PQI: Regorafenib (Stivarga®) in the Treatment of Hepatocellular Carcinoma

PQI: Durvalumab (Imfinzi®) Therapy Overview

Treatment Support Kit: Cabozantinib

PQI: Tivozanib (Fotivda®) for Relapsed or Refractory Advanced Renal Cell Carcinoma

S7 Ep 2: Insights on Navigating Kidney Cancer Care

Treatment Support Kit: Tivozanib

Treatment Support Kit: Cabozantinib

PQI: Selpercatinib (Retevmo®) Management

PQI: Selpercatinib (Retevmo®) Genomic Testing Management

Treatment Support Kit: Cabozantinib

Treatment Support Kit: Cabozantinib

Treatment Support Kit: Cabozantinib

PQI: Zolbetuximab (Vyloy®) for Gastroesophageal Cancers

PQI in Action: Larotrectinib (Vitrakvi®) Overview

PQI: Advances in MRD Monitoring for Diffuse Large B-Cell Lymphoma (DLBCL)

S8 Ep 13: Supporting Patients Through Financial Assistance